Hubei Fuxing Biotechnology Co., Ltd.（湖北福星生物科技有限公司）is a high-tech enterprise specializing in the research, development, and production of polyunsaturated fatty acids (PUFAs), particularly Arachidonic Acid (ARA) and Docosahexaenoic Acid (DHA). Located in Hanchuan City, Hubei Province, China, the company is a pioneer in microbial fermentation technology for nutritional lipids and a critical supplier to the global infant nutrition, dietary supplement, and functional food industries.
Core Business
Fuxing Biotechnology focuses on the industrial-scale production of microbial-sourced ARA and DHA, both essential long-chain polyunsaturated fatty acids (LCPUFAs) with critical roles in human development, especially in infants. The company’s expertise spans strain development, fermentation, extraction, purification, and microencapsulation, enabling stable supply of high-purity nutritional lipids.
Product & Service Offerings
The core product portfolio includes:
-
Arachidonic Acid (ARA) Oil
- High-purity omega-6 fatty acid produced via fungal fermentation (Mortierella alpina)
- Widely used in infant formula, pediatric supplements, and pharmaceutical emulsions
-
Arachidonic Acid (ARA) Powder
- Microencapsulated for improved stability and bioavailability
- Designed for dry-blend formulas, tablets, and functional food applications
-
Docosahexaenoic Acid (DHA) Oil
- Omega-3 fatty acid sourced from microalgae (Schizochytrium spp.)
- Applied in cognitive development supplements, pregnancy nutrition, and infant formulations
-
Docosahexaenoic Acid (DHA) Powder
- Stable, dry formulation suited for nutritional powders, beverages, and confectionery health products
All products undergo extensive QA/QC, including tests for oxidation, heavy metals, pesticide residues, and microbial safety.
Specialisation and Core USP
Fuxing Biotechnology’s strengths lie in:
- Proprietary microbial fermentation processes
- Integrated production from strain isolation to finished lipid powder
- Microencapsulation technology ensuring oxidation resistance and shelf stability
- Proven safety and efficacy in infant and maternal nutrition
Its core USP is offering dual-chain fatty acid solutions (ARA + DHA) from a single supplier with certified infant-grade purity.
Financials and Operational Scale
Fuxing operates on a national and international scale:
- Annual production capacity: 300+ metric tons of ARA and DHA combined
- Facility area spans over 30,000 square meters
- Estimated annual revenue: USD 20–30 million
- Active supply partnerships with leading infant formula manufacturers in China, Southeast Asia, and Latin America
The company maintains an advanced production site compliant with GMP and food-grade standards.
Shipment and Export Data
According to export records and industry data:
- Over 70 recorded international shipments (2020–2024)
- Main destinations: Vietnam, Indonesia, Brazil, India, Russia
- Exported in 20 kg and 190 kg drum formats (oil) and 10–25 kg vacuum-sealed bags (powder)
- Shipment values typically range between USD 10,000 and 60,000, depending on grade and volume
Custom export formulations and documentation are available per client requirements.
Target Market
- Infant formula producers
- Nutritional supplement brands
- Maternal and prenatal health product manufacturers
- Functional food and beverage companies
- Export distributors of nutritional ingredients
Fuxing supports both multinational companies and regional OEM brands with flexible supply contracts.
Capabilities
- In-house fermentation reactors, lipid extraction systems, and spray-drying units
- R&D team with backgrounds in lipid chemistry, food technology, and microbial engineering
- Pilot-to-commercial scalability with custom powder particle sizing
- Advanced oxidation prevention systems for PUFA stabilization
- Regulatory expertise for global export registration and compliance
Certifications and Compliance
- ISO 9001:2015 Quality Management System
- HACCP Certification
- Halal and Kosher Certifications
- China CFDA Registration for food-grade oils and powders
- Aligns with Codex Alimentarius, EU Novel Food, and US FDA GRAS standards
- Documentation includes COA, MSDS, TDS, and traceability batch records
Products are routinely tested by third-party labs for purity and safety.
Customer Testimonials
Buyers and partners have recognized Fuxing for:
- Consistently high purity and low peroxide values in PUFA oils
- Excellent encapsulation stability in powder products with long shelf life
- Responsive technical and regulatory support for formulation and compliance
- Timely delivery and reliable production scheduling even under high-volume orders
Feedback from Southeast Asian infant nutrition manufacturers highlights ARA oil clarity and performance in emulsions.
Major Achievements
- Among the top three ARA suppliers in China by output
- Developed dual encapsulated DHA+ARA premix system for direct use in infant formula blends
- Patents filed on oxidation-resistant lipid encapsulation techniques
- Participated in national industrial innovation programs for nutritional lipid development
- Expanded to serve OEM clients in Europe and South America through regulatory alignment
Hubei Fuxing Biotechnology Co., Ltd. remains a cornerstone of China’s lipid biotechnology sector, delivering safe, science-backed, and high-performance nutritional ingredients for global health and wellness industries.
